Bronchial artery hypertrophy is correlated with coronary artery disease

Silvia Tresoldi1, Giovanni Di Leo, Federica Villa

  • 1Servizio di Radiologia Diagnostica ed Interventistica, Azienda Ospedaliera San Paolo, Milan, Italy.

Insights

Coronary artery disease (CAD) is associated with bronchial artery hypertrophy (BAH). In patients without lung disease, BAH may indicate undiagnosed CAD, suggesting a link between the two conditions.

Area of Science:

  • Cardiovascular Research
  • Pulmonary Medicine
  • Radiology

Background:

  • Bronchial arteries (BA) play a role in the systemic pulmonary vasculature, connecting with pulmonary and coronary arteries.
  • While bronchial artery hypertrophy (BAH) is linked to pulmonary diseases, its association with coronary artery disease (CAD) is less understood.
  • Understanding the BA-CAD relationship is crucial for comprehensive cardiovascular and pulmonary assessment.

Purpose of the Study:

  • To investigate the potential association between bronchial artery hypertrophy (BAH) and coronary artery disease (CAD).
  • To evaluate this relationship in patients undergoing computed tomography coronary angiography (CTCA) without known pulmonary diseases.

Main Methods:

  • Retrospective analysis of 100 patients who underwent CTCA, stratified by CAD severity and treatment (no/non-significant CAD, significant CAD, stented, bypass grafts).
  • Quantification of bronchial artery number and diameter.
  • Correlation analysis between age, CAD status, and bronchial artery parameters.

Main Results:

  • Over 50% of detected bronchial arteries were hypertrophic (diameter >1.5 mm).
  • Bronchial artery diameter significantly correlated with the presence and severity of CAD and patient age.
  • No significant association was found between bronchial artery diameter and pulmonary findings.

Conclusions:

  • A significant association exists between coronary artery disease (CAD) and bronchial artery hypertrophy (BAH).
  • BAH may serve as an indicator of underlying, potentially undiagnosed CAD, especially in individuals without evident pulmonary pathology.
  • This finding highlights a potential link between systemic and pulmonary vasculature that warrants further investigation.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Angina I: Introduction01:30

Angina I: Introduction

Definition and Symptoms: Angina (angina pectoris) is chest pain or discomfort caused by myocardial ischemia, which occurs when the heart muscle receives insufficient oxygen-rich blood. It typically manifests as pressing, squeezing, or crushing sensations in the chest and may radiate to the shoulders, arms, neck, jaw, or back.Primary Cause: In a healthy state, the coronary arteries can dilate (widen) to increase blood flow and meet the increased oxygen demand during physical activity or...